Finds traits that predict weight loss success and long-term weight maintenance in obesity
Studies personal traits that may predict weight loss and weight maintenance in adults with obesity.
Key facts
- Who runs it
- University of Michigan
- Where
- Ann Arbor, United StatesSee the site
- Trial code
- Registry title
- Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
- Status
- Recruiting
- People taking part
- 3,200 people, planned
- Started
- Aug 2009
- Expected to end
- Dec 2030
- Type of study
- Observational
- Treatments tested
- phenotyping
- Record updated
- 13 July 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with obesity (BMI 27 or higher), and also for lean people (BMI above 17 and below 27), to study what predicts success in weight loss and keeping weight off.
- Age
- Over 20 years in the inclusion criteria; the registry lists 15 Years to 75 Years.
- Sex
- Men and women can join.
- Disease stage
- Obese people have a BMI of 27 kg/m2 or more. Lean people have a BMI above 17 and below 27 kg/m2.
- Earlier treatment
- People with prior bariatric surgery cannot join. Taking part in another clinical trial within 90 days is also not allowed.
Main reasons for not taking part
- Prior bariatric surgery
- Cancer within the last 5 years
- HIV antibody positive, or a solid organ transplant
- Pregnant or breastfeeding women
- Body weight change of more than 5 kg (11 lb) in the previous 3 months
The registry criteria, word for word
Show all 21 criteriaShow less
Who can take part
- Obese males and females: age >20 years; Obese population defined as BMI > or = 27 kg/m2
- Lean population BMI < 27 but > 17 kg/m2
- Able and willing to provide written informed consent for the trial
Who cannot take part
- Body weight fluctuation of more than 5 kg in the previous 3 months
- Prior bariatric surgery
- Evidence of inherited disorders of lipid metabolism
- History of Cancer within the last 5 years
- Human immunodeficiency virus (HIV) antibody positive
- Uncontrolled thyroid disease
- Unstable angina or NY heart association class II failure or above
- Gastrointestinal disease specifically GI motility disorders
- Unstable neuropsychiatric disease including major depression/anxiety, eating disorder such as binge eating, bulimia or anorexia
- End stage renal or hepatic disease
- Autoimmune disorders (e.g. SLE)
- Any medical condition, which in the opinion of the investigator would make the patient unsuitable for recruitment, or could interfere with the patient participating in or completing the protocol
- Women of childbearing age must use a reliable form of contraception
- Patients with solid organ transplants
- Participation in any other clinical trial within 90 days of entry into this trial
- Pregnant or lactating females
- A history or current alcohol/substance abuse and change in smoking habits or cessation in the past 6 months
- Unwilling or unable to consent for the study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 15 and 75 years old?
Where in United States
- University of MichiganAnn Arbor, United StatesContact: Amy E Rothberg, MD, PhDTaking people
About the trial
What the trial wants to find out
The Investigational Weight Management Clinic now entitled the Weight Management Program at the University of Michigan was created to identify strategies that will result in cost-effective, long term weight management for overweight and obese individuals. The driving hypothesis of the clinic is that the 'one size fits all' philosophy is untenable with a complex disease such as obesity. The clinic will serve as a portal for patients to choose standard clinical care or to explore alternatives from a variety of clinical studies offered through the clinic. These studies will include further investigations into nutrition, the biological basis of weight and weight management and protocols using approved and experimental pharmaceuticals as well as technologies that aid in self-management of weight.
The group in the trial
- Lifestyle intervention
Opt-in intervention to include the following procedures, called 'phenotyping' performed at baseline, after 10-15% weight loss from baseline weight or 6 months (whichever comes first) and at end of 2 years while in weight maintenance: oral glucose tolerance test, mixed meal tolerance test, with fasting leptin, biased and unbiased metabolomic profiling, DNA, RNA, muscle and adipose tissue biopsies: measurement of resting energy expenditure by indirect calorimetry; oxidative capacity (V02 peak/max); body composition by Dual Energy X-ray Absorptiometry (DEXA) or air displacement plethysmograph (Bod Pod); inventories of depression and health related quality of life instruments, measures of impulsivity, measures of hunger and appetite, work performance (including presenteeism and absenteeism) and pain survey.
Treatment: phenotyping
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance
- Plain-language title
- Finds traits that predict weight loss success and long-term weight maintenance in obesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT02043457, who can take part
- Publications
- Record updated
- 13 July 2026